ES557286A0 - Prcedimiento para preparar nuevos derivados aminicos heteroaromaticos - Google Patents
Prcedimiento para preparar nuevos derivados aminicos heteroaromaticosInfo
- Publication number
- ES557286A0 ES557286A0 ES557286A ES557286A ES557286A0 ES 557286 A0 ES557286 A0 ES 557286A0 ES 557286 A ES557286 A ES 557286A ES 557286 A ES557286 A ES 557286A ES 557286 A0 ES557286 A0 ES 557286A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- preparing new
- amin
- derivatives
- new heteroaromatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853519735 DE3519735A1 (de) | 1985-06-01 | 1985-06-01 | Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE19853522552 DE3522552A1 (de) | 1985-06-24 | 1985-06-24 | Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8800202A1 ES8800202A1 (es) | 1987-10-16 |
| ES557286A0 true ES557286A0 (es) | 1987-10-16 |
Family
ID=25832780
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES555513A Expired ES8704938A1 (es) | 1985-06-01 | 1986-05-30 | Procedimiento para preparar nuevos derivados aminicos heteroaromaticos |
| ES557286A Expired ES8800202A1 (es) | 1985-06-01 | 1987-01-09 | Prcedimiento para preparar nuevos derivados aminicos heteroaromaticos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES555513A Expired ES8704938A1 (es) | 1985-06-01 | 1986-05-30 | Procedimiento para preparar nuevos derivados aminicos heteroaromaticos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4737495A (es) |
| EP (1) | EP0204349A3 (es) |
| KR (1) | KR870000323A (es) |
| AU (1) | AU585351B2 (es) |
| DK (1) | DK255086A (es) |
| ES (2) | ES8704938A1 (es) |
| FI (1) | FI79846C (es) |
| GR (1) | GR861419B (es) |
| HU (1) | HUT43587A (es) |
| IL (1) | IL78970A (es) |
| NO (1) | NO862159L (es) |
| NZ (1) | NZ216360A (es) |
| PT (1) | PT82661B (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4972273A (en) * | 1984-10-15 | 1990-11-20 | Burkhardt Norman S | High speed, high resolution image processing system |
| DE3631013A1 (de) * | 1986-09-12 | 1988-03-24 | Thomae Gmbh Dr K | Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| GB8707120D0 (en) * | 1987-03-25 | 1987-04-29 | Pfizer Ltd | Antiarrhythmic agents |
| JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
| US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| JP3497164B2 (ja) * | 1991-06-28 | 2004-02-16 | スミスクライン・ビーチャム・コーポレイション | 二環式フィブリノーゲン拮抗薬 |
| MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
| US6458784B1 (en) | 1994-06-29 | 2002-10-01 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
| US20030125317A1 (en) * | 1996-10-02 | 2003-07-03 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| JP4920409B2 (ja) | 2003-06-17 | 2012-04-18 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ３−ベンズアゼピンを調製する方法 |
| CN1805938B (zh) | 2003-06-17 | 2010-06-16 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物 |
| PL1667964T3 (pl) | 2003-09-19 | 2010-01-29 | Janssen Pharmaceutica Nv | Kwasy 4-((fenoksyalkilo)tio)-fenoksyoctowe i analogi |
| FR2868776B1 (fr) * | 2004-04-13 | 2008-04-18 | Servier Lab | Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2868775B1 (fr) * | 2004-04-13 | 2008-04-11 | Servier Lab | Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2868777B1 (fr) * | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| EA015012B1 (ru) | 2004-12-23 | 2011-04-29 | Арена Фармасьютикалз, Инк. | Композиция, содержащая фентермин и избирательный агонист рецептора 5ht, и ее применение |
| JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| US8168782B2 (en) | 2006-04-03 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
| PE20080188A1 (es) | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol |
| US8299241B2 (en) | 2006-12-05 | 2012-10-30 | Arena Pharmaceuticals, Inc. | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
| WO2009111004A1 (en) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
| FR2932800B1 (fr) * | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| US20090320724A1 (en) * | 2008-06-27 | 2009-12-31 | Walburn William L | Swivel base with installation aid |
| CN101774969B (zh) * | 2009-01-13 | 2012-07-04 | 江苏恒瑞医药股份有限公司 | 硫酸伊伐布雷定及其i型结晶的制备方法 |
| US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법 |
| SG10201506865WA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Non-hygroscopic salts of 5-ht2c agonists |
| CN107669687A (zh) | 2010-09-01 | 2018-02-09 | 艾尼纳制药公司 | 用于体重控制的5‑ht2c激动剂的调节释放剂型 |
| SG10201506896RA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
| US9248133B2 (en) | 2010-09-01 | 2016-02-02 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
| AR088670A1 (es) | 2012-10-09 | 2014-06-25 | Arena Pharm Inc | Metodo de control del peso |
| FR3003859B1 (fr) * | 2013-03-26 | 2015-03-13 | Servier Lab | "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine" |
| AU2022328217A1 (en) | 2021-08-12 | 2024-03-14 | Kuleon Llc | Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4490369A (en) * | 1981-05-19 | 1984-12-25 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Benzazepine derivatives, their pharmaceutical compositions and method of use |
| DE3119874A1 (de) * | 1981-05-19 | 1982-12-09 | Dr. Karl Thomae Gmbh, 7950 Biberach | "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel" |
| DE3343801A1 (de) * | 1983-12-03 | 1985-06-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue indolderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
-
1986
- 1986-05-21 EP EP86107836A patent/EP0204349A3/de not_active Withdrawn
- 1986-05-28 PT PT82661A patent/PT82661B/pt not_active IP Right Cessation
- 1986-05-28 KR KR860004183A patent/KR870000323A/ko not_active Application Discontinuation
- 1986-05-29 FI FI862270A patent/FI79846C/fi not_active IP Right Cessation
- 1986-05-30 ES ES555513A patent/ES8704938A1/es not_active Expired
- 1986-05-30 NO NO862159A patent/NO862159L/no unknown
- 1986-05-30 NZ NZ216360A patent/NZ216360A/xx unknown
- 1986-05-30 US US06/868,986 patent/US4737495A/en not_active Expired - Fee Related
- 1986-05-30 AU AU58216/86A patent/AU585351B2/en not_active Ceased
- 1986-05-30 GR GR861419A patent/GR861419B/el unknown
- 1986-05-30 HU HU862287A patent/HUT43587A/hu unknown
- 1986-05-30 IL IL78970A patent/IL78970A/xx not_active IP Right Cessation
- 1986-05-30 DK DK255086A patent/DK255086A/da not_active Application Discontinuation
-
1987
- 1987-01-09 ES ES557286A patent/ES8800202A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GR861419B (en) | 1986-09-26 |
| FI862270A0 (fi) | 1986-05-29 |
| AU585351B2 (en) | 1989-06-15 |
| ES8704938A1 (es) | 1987-04-16 |
| FI862270A (fi) | 1986-12-02 |
| KR870000323A (ko) | 1987-02-17 |
| EP0204349A3 (de) | 1990-01-03 |
| IL78970A0 (en) | 1986-09-30 |
| PT82661B (pt) | 1988-11-30 |
| DK255086D0 (da) | 1986-05-30 |
| AU5821686A (en) | 1986-12-04 |
| DK255086A (da) | 1986-12-02 |
| HUT43587A (en) | 1987-11-30 |
| PT82661A (de) | 1986-06-01 |
| NZ216360A (en) | 1989-05-29 |
| FI79846B (fi) | 1989-11-30 |
| ES8800202A1 (es) | 1987-10-16 |
| EP0204349A2 (de) | 1986-12-10 |
| ES555513A0 (es) | 1987-04-16 |
| FI79846C (fi) | 1990-03-12 |
| IL78970A (en) | 1990-06-10 |
| NO862159L (no) | 1986-12-02 |
| US4737495A (en) | 1988-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES557286A0 (es) | Prcedimiento para preparar nuevos derivados aminicos heteroaromaticos | |
| ES557241A0 (es) | Procedimiento para preparar nuevos 2-aril-imidazoles | |
| ES557213A0 (es) | Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos | |
| ES548921A0 (es) | Procedimiento para preparar nuevos derivados de aminotetra- lina | |
| ES540464A0 (es) | Procedimiento para preparar derivados de pleuromutilina | |
| ES557522A0 (es) | Procedimiento para preparar derivados de cinolina | |
| ES551807A0 (es) | Procedimiento para preparar piridinil acilhidrazonas | |
| ES550875A0 (es) | Procedimiento para preparar derivados de imidazolilalquil- quilguanidina | |
| ES556514A0 (es) | Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona | |
| ES552955A0 (es) | Procedimiento para preparar derivados de bencimidazol substituidos | |
| ES539717A0 (es) | Procedimiento para preparar derivados azolilalquilicos | |
| ES551733A0 (es) | Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol | |
| ES553851A0 (es) | Procedimiento para preparar derivados de nitrofurano | |
| ES557019A0 (es) | Un procedimiento para la preparacion de derivados aminicos | |
| ES553814A0 (es) | Un procedimiento para preparar nuevos derivados de aminocetona | |
| ES554832A0 (es) | Procedimiento para preparar derivados alquenicos. | |
| ES554371A0 (es) | Procedimiento para preparar derivados de benzisoselenazolilo | |
| ES557630A0 (es) | Procedimiento para preparar dihidropiridinas | |
| ES554828A0 (es) | Procedimiento para preparar derivados de fluoralcanos. | |
| ES552258A0 (es) | Procedimiento para preparar derivados de ergolina | |
| ES555036A0 (es) | Procedimiento para preparar derivados de oxadiazolilimidazobenzodiazepina | |
| ES541140A0 (es) | Procedimiento para preparar derivados carboxialquildipepti- dicos | |
| ES554133A0 (es) | Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas | |
| ES543014A0 (es) | Procedimiento para preparar nuevos derivados de quinoleina | |
| ES557625A0 (es) | Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |
Effective date: 19960506 |